IZUN PHARMACEUTICALS CORP
Plant-derived pharmaceutical compounds identified and optimized through proprietary extraction and analytics platform
- Sector
- Biotech
- Headquarters
- JERUSALEM, L3
- Latest Form D
- $1.1M, Nov 2014
- Total capital
- $5.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $5.2M
- 2 Form D · last Nov 2014
- 144 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 5 pending · first 2019
- Rank in peer group#213 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$1.1M
- Private capital raisedForm D · SEC · 1st filing$4.1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#213 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- William Z LevineResearcherExecutive Officer, DirectorLinked by 3 patents
- Aron Z SafferExecutive Officer, DirectorNamed in SEC Form D filings
- Avner Z RotmanDirectorNamed in SEC Form D filings
- Benjamin Z JesselsonDirectorNamed in SEC Form D filings
- Elliot Z HahnDirectorNamed in SEC Form D filings
- Hersch Z CooperDirectorNamed in SEC Form D filings
Show all 10 people
- Jeremy Z KonDirectorNamed in SEC Form D filings
- Oscar Z SchaferDirectorNamed in SEC Form D filings
- Robert Z CitronExecutive OfficerNamed in SEC Form D filings
- Yarom Z OrenDirectorNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 12- GrantedProtein Based Cannabis CompositionsUSPTOUS 12,220,438
- GrantedHydrogel Wound TreatmentUSPTOUS 12,171,796
- GrantedMethods For Preparing Anti-inflammatory Herbal Extracts Comprising Sambucus Nigra, Echinacea Purpurea And Centella AsiaticaUSPTOUS 12,059,445
Show all 12 patent records
- Protein Based Cannabis CompositionsFeb 11, 2025 · US 12,220,438Granted
- Hydrogel Wound TreatmentDec 24, 2024 · US 12,171,796Granted
- Methods For Preparing Anti-inflammatory Herbal Extracts Comprising Sambucus Nigra, Echinacea Purpurea And Centella AsiaticaAug 13, 2024 · US 12,059,445Granted
- Stabilized Protein-bound Cannabinoid CompositionsJun 25, 2024 · US 12,016,838Granted
- Treatment Of Oral MucositisDec 7, 2023 · Application 18250760Pending
- Cannabinoid Compositions And Methods Of Use ThereofNov 22, 2022 · US 11,504,350Granted
- Protein Based Cannabis CompositionsAug 25, 2022 · Application 17638827Pending
- Cannabinoid Formulations And DosageApr 29, 2021 · Application 16494320Pending
- Water-based Cannabinoid And Opioid CompositionsMay 19, 2020 · US 10,653,787Granted
- Methods For Treatment Of M-tor Inhibitor-associated StomatitisMay 21, 2019 · US 10,293,010Granted
- Plant Matter Smoke And Vapor Collection DeviceApplication 62393284Pending
- Water-based Cannabinoid And Opioid CompositionsApplication 62096558Pending
Related companies, and why
- Propanc Biopharma, Inc.Similar federal contract value in Biotech · null in contracts
- CHINA PHARMA HOLDINGS, INC.Similar federal contract value in Biotech · null in contracts
- iToleranceSimilar federal contract value in Biotech · null in contracts
- Alterome TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Outpace BioSimilar federal contract value in Biotech · null in contracts
- Chemomab Therapeutics Ltd.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .